Approval · Notice of Compliance 16601 · 2015
IMURAN: Notice of Compliance 16601
Issued February 13, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16601
- Date
- February 13, 2015
- Company
- Aspen Pharma Trading Limited
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Immunosuppressive agent
Products in this notice
Medicinal ingredients
- AZATHIOPRINE 50 MG per TAB
- AZATHIOPRINE SODIUM 50 MG per VIAL